Author: William C. Shiel Jr., MD, FACP, FACR
Your rheumatoid arthritis is causing
you daily pain and stiffness in your fingers, wrists, and knees. It is difficult
for you to dress and care for yourself. You've tried numerous traditional
medications, which have failed to improve your conditions and the threat of
permanent joint damage is lurking.
So, your doctor recommends a new treatment for your aggressive rheumatoid arthritis. The treatment is given directly into your veins (intravenously or IV). The treatment is extremely expensive, but side effects are uncommon. The treatment is Remicade (generic name is infliximab).
What is Remicade?
Remicade is an antibody that blocks the effects of tumor necrosis factor alpha (TNF-alpha). TNF- alpha is a substance that is produced by cells of the body and that has an important role in promoting inflammation. Basically, TNF-alpha acts like a messenger that summons the immune cells of inflammation to participate in the inflammation.
By blocking the action of TNF-alpha, Remicade reduces the inflammation and its accompanying signs and symptoms. Remicade does not cure rheumatoid arthritis. However, studies have demonstrated that Remicade can inhibit the progress of joint destruction from rheumatoid arthritis.
Remicade can either be used alone or is often combined with methotrexate for treating rheumatoid arthritis in patients who have not adequately responded to methotrexate alone. In these patients, the drug is used to prevent joint damage that is caused by the rheumatoid arthritis.
Rheumatoid arthritis is a chronic (long-standing) joint disease that damages the joints of the body. The damage is caused by inflammation of the joint lining tissue. Inflammation is normally a response by the body's immune system to "assaults" such as infections, wounds, and foreign objects. In rheumatoid arthritis, the inflammation is misdirected to attack the joints. Rheumatoid arthritis is often referred to as RA.
Rheumatoid arthritis should not be confused with other forms of arthritis, such as osteoarthritis or arthritis associated with infections. Rheumatoid arthritis is an autoimmune disease. This means that the body's immune system mistakenly attacks the tissues it is supposed to protect.
Rheumatoid arthritis most often affects the smaller joints, such as those of the hands and/or feet, wrists, elbows, knees, and/or ankles. The symptoms often lead to significant discomfort and disability.
Although rheumatoid arthritis most often affects the joints, it is a disease of the entire body. It can affect many organs and body systems besides the joints. Therefore, rheumatoid arthritis is sometimes referred to as a systemic disease.
Like many autoimmune diseases, rheumatoid arthritis typically waxes and wanes. Most people with rheumatoid arthritis experience periods when their symptoms worsen (known as flares or active disease) separated by periods in which the symptoms improve. With successful treatment, symptoms may even go away completely (remission, or inactive disease).
About 1.3 million people in the United States are believed to have rheumatoid arthritis.
Although there is no cure for rheumatoid arthritis, the disease can be controlled in most people. Early, aggressive therapy to stop or slow down inflammation in the joints can prevent or reduce symptoms, prevent or reduce joint destruction and deformity, and prevent or lessen disability and other complications.
| Printer-Friendly Format | | | Email to a Friend |
Get the latest treatment options
Cymbalta is approved for the treatment of fibromyalgia.
Important Safety Information
Cymbalta® (duloxetine HCl) is approved for the treatment of depression and generalized anxiety disorder, and for the management of diabetic peripheral neuropathic pain and fibromyalgia.
Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, unusual changes in behavior, thoughts of suicide, anxiety, agitation, panic attacks, difficulty sleeping, irritability, hostility, aggressiveness, impulsivity, restlessness, or extreme hyperactivity. Call your healthcare provider right away if you have thoughts of suicide or if any of these symptoms are severe or occur suddenly. Be especially observant within the first few months of antidepressant treatment or whenever there is a change in dose.
You should not take Cymbalta if:
Before starting Cymbalta, tell your healthcare provider:
While taking Cymbalta, tell your healthcare provider:
If you have any questions, talk to your healthcare provider before taking Cymbalta.
The most common side effect of Cymbalta was nausea. For most people who had it, the nausea was mild to moderate. Other common side effects included dry mouth, sleepiness, constipation, decreased appetite, and, increased sweating. This is not a complete list of side effects.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease of unknown cause that primarily affects the peripheral joints in a symmetric pattern.
|